Mohammed M. Jan

Dr. Mohammed M. Jan


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
NANoran M. Abu-Ouf
Noran M. Abu-Ouf
MJMohammed M. Jan
Mohammed M. Jan
The impact of maternal iron deficiency and iron deficiency anemia on child’s health

1 May 2011 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
FAFowzan S. Alkuraya
Fowzan S. Alkuraya
XCXuyu Cai
Xuyu Cai
CECarina Emery
Carina Emery
GMGaneshwaran H. Mochida
Ganeshwaran H. Mochida
MAMohammed S. Al-Dosari
Mohammed S. Al-Dosari
CWChristopher A. Walsh
Christopher A. Walsh

1 March 2006 in Annals of Saudi Medicine
Verified
Journal Article
Closed access
MJMohammed M. Jan
Mohammed M. Jan
Cerebral palsy (CP) is a common pediatric disorder occurring in about 2 to 2.5 per 1000 live births. It is a chronic motor disorder resulting from a non-progressive (static) insult to the developing brain. CP is the clinical presentation of a wide variety of cerebral cortical or sub-cortical insults occurring during the first year of life. The commonest cause of CP remains unknown in 50% of the cases; prematurity remains the commonest risk factor. Children with CP suffer from multiple problems and potential disabilities such as mental retardation, epilepsy, feeding difficulties, and ophthalmologic and hearing impairments. Screening for these conditions should be part of the initial assessment. The child with CP is best cared for with an individualized treatment plan that provides a combination of interventions. This requires the provision of a number of family-centered services that make a difference in the lives of these children and their families. Management of spasticity can be challenging with a wide variety of possible therapeutic interventions. The treatment must be goal oriented, such as to assist with mobility, reduce or prevent contractures, improve positioning and hygiene, and provide comfort. Each member of the child's multidisciplinary team, including the child and both parents, should participate in the serial evaluations and treatment planning.

1 April 2014 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
AAAlbaraa S. Abulhamail
Albaraa S. Abulhamail
FAFahad E. Al-Sulami
Fahad E. Al-Sulami
MAMouneeb A. Alnouri
Mouneeb A. Alnouri
NMNajeeb M. Mahrous
Najeeb M. Mahrous
DJDima G. Joharji
Dima G. Joharji
MJMohammed M. Jan
Mohammed M. Jan

1 May 2009 in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Verified
Journal Article
Open access
PDF file
YAYousef A. Al-Said
Yousef A. Al-Said
HAHiyam S. Al-Rached
Hiyam S. Al-Rached
HAHussien A. Al-Qahtani
Hussien A. Al-Qahtani
MJMohammed M. Jan
Mohammed M. Jan
Background: Osteomalacia is an uncommon cause of muscle weakness. Our objectives were to describe features of myopathy associated with Vitamin D deficiency and examine the contributing factors leading to osteomalacic myopathy in our region. Methods: Patients identified retrospectively for the six year period ending in December 2006 with the diagnosis of osteomalacia and/or Vitamin D deficiency associated proximal muscle weakness were included. They were followed in three major centers in western Saudi Arabia. Clinical, biochemical, radiological, and electrophysiological findings were collected before and after Vitamin D treatment by chart review. Results: Forty seven female patients aged 13-46 years (mean 23.5, SD 4.5) were included. All were veiled and covered heavily when outside the house for social and cultural reasons. Only eight (17%) had adequate varied diet with daily milk ingestion. All patients presented with progressive proximal muscle weakness lasting 6-24 months (mean 14) prior to our evaluation. The weakness was severe in six (13%) patients leading to wheel chair bound states. Associated musculoskeletal pain involving the back, hips, or lower limbs was common (66%). Osteomalcia was the referral diagnosis in only 11 patients and the remaining 36 (77%) patients were misdiagnosed. All patients had metabolic and radiological profiles suggestive of osteomalacia. Remarkable recovery was documented in all patients following oral cholecalciferol and calcium supplementation. Conclusions: Vitamin D deficiency is an important treatable cause of osteomalacic myopathy in Saudi Arabia. The diagnosis is frequently delayed or missed. Screening for Vitamin D deficiency in patients with acquired myopathy is needed to identify this treatable disorder.

1 September 2000 in Pediatric Neurology
Verified
Journal Article
Closed access
MJMohammed M. Jan
Mohammed M. Jan